An ATRActive future for differentiation therapy in AML
- 21 January 2015
- journal article
- Published by Elsevier BV in Blood Reviews
- Vol. 29 (4), 263-268
- https://doi.org/10.1016/j.blre.2015.01.002
Abstract
No abstract availableKeywords
Funding Information
- LLS Translational Research Award (6028-10)
- NIH (P30 CA047904)
This publication has 69 references indexed in Scilit:
- The combination of valproic acid, all-trans retinoic acid and low-dose cytarabine as disease-stabilizing treatment in acute myeloid leukemiaClinical Epigenetics, 2013
- Azacitidine might be beneficial in a subgroup of older AML patients compared to intensive chemotherapy: a single centre retrospective study of 227 consecutive patientsJournal of Hematology & Oncology, 2013
- The Addition of All-Trans Retinoic Acid to Chemotherapy May Not Improve the Outcome of Patient with NPM1 Mutated Acute Myeloid LeukemiaFrontiers in Oncology, 2013
- Retinoid Differentiation Therapy for Common Types of Acute Myeloid LeukemiaLeukemia Research and Treatment, 2012
- Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemiaNature Medicine, 2012
- The Proteasome Inhibitor Bortezomib Enhances ATRA-Induced Differentiation of Neuroblastoma Cells via the JNK Mitogen-Activated Protein Kinase PathwayPLOS ONE, 2011
- DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid LeukemiaCancer Cell, 2010
- Combined Bezafibrate and Medroxyprogesterone Acetate: Potential Novel Therapy for Acute Myeloid LeukaemiaPLOS ONE, 2009
- Retinoid Signaling Is Attenuated by Proteasome-Mediated Degradation of Retinoid Receptors in Human Keratinocyte HaCaT CellsExperimental Cell Research, 2002
- Serine 157, a Retinoic Acid Receptor α Residue Phosphorylated by Protein Kinase C in Vitro, Is Involved in RXR·RARα Heterodimerization and Transcriptional ActivityJournal of Biological Chemistry, 1999